摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Methyl <2-(trimethylsilyl)ethyl 5-acetamido-4-O-benzoyl-3,5-dideoxy-9-O-(p-methoxybenzyl)-D-glycero-α-D-galacto-2-nonulopyranosid>onate | 164030-10-8

中文名称
——
中文别名
——
英文名称
Methyl <2-(trimethylsilyl)ethyl 5-acetamido-4-O-benzoyl-3,5-dideoxy-9-O-(p-methoxybenzyl)-D-glycero-α-D-galacto-2-nonulopyranosid>onate
英文别名
2-(trimethylsilyl)ethyl (methyl 5-acetamido-4-O-benzoyl-3,5-dideoxy-9-O-p-methoxybenzyl-D-glycero-α-D-galacto-non-2-ulopyranosid)onate;methyl (2R,4S,5R,6R)-5-acetamido-4-benzoyloxy-6-[(1R,2R)-1,2-dihydroxy-3-[(4-methoxyphenyl)methoxy]propyl]-2-(2-trimethylsilylethoxy)oxane-2-carboxylate
Methyl <2-(trimethylsilyl)ethyl 5-acetamido-4-O-benzoyl-3,5-dideoxy-9-O-(p-methoxybenzyl)-D-glycero-α-D-galacto-2-nonulopyranosid>onate化学式
CAS
164030-10-8
化学式
C32H45NO11Si
mdl
——
分子量
647.795
InChiKey
GDZGFVRFXGEZCM-DLJNZENESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.68
  • 重原子数:
    45
  • 可旋转键数:
    17
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    159
  • 氢给体数:
    3
  • 氢受体数:
    11

反应信息

  • 作为反应物:
    描述:
    Methyl <2-(trimethylsilyl)ethyl 5-acetamido-4-O-benzoyl-3,5-dideoxy-9-O-(p-methoxybenzyl)-D-glycero-α-D-galacto-2-nonulopyranosid>onatemethyl onate甲磺酰溴 、 MS (3 Angstroem) 、 silver trifluoromethanesulfonate 作用下, 以 二氯甲烷乙腈 为溶剂, 反应 4.5h, 以44%的产率得到methyl [2-(trimethylsilyl)ethyl (methyl 4,7,8,9-tetra-O-acetyl-5-N,N-diacetylamino-3,5-dideoxy-3-phenylthio-D-erythro-β-L-gluco-non-2-ulopyranosylonate)-(2->8)-5-acetamido-4-O-benzoyl-3,5-dideoxy-9-O-p-methoxybenzyl-D-glycero-α-D-galacto-non-...]
    参考文献:
    名称:
    一种新型的立体选择性α-唾液酸化供体;α(2-8)连接的双唾液酸单元的高效合成
    摘要:
    新的唾液酸供体甲基5-(N,N-二乙酰基)-4,7,8,9-四-O-乙酰基-2-硫代-3-硫代苯基-2,3,5-三苯氧基-D-赤型通过对相应的5-乙酰氨基化合物1进行N-乙酰化,合成了-L-葡萄糖-2-壬基吡喃糖苷(2)。具有一个或两个未保护的羟基的单糖和二糖苷元的α-唾液酸化以高收率提供了相应的二糖和三糖,并且具有几乎完全的区域选择性和立体选择性。作为一个实例,因此以44%的收率获得了Neu5Acα(2→8)Neu5Ac衍生物。没有观察到相应的β端基异构体。
    DOI:
    10.1016/s0040-4039(99)00175-6
  • 作为产物:
    描述:
    (2R,4S,5R,6R)-5-Acetylamino-4-benzoyloxy-6-[(4R,5R)-5-hydroxy-2-(4-methoxy-phenyl)-[1,3]dioxan-4-yl]-2-(2-trimethylsilanyl-ethoxy)-tetrahydro-pyran-2-carboxylic acid methyl ester 在 三氯化铝硼烷-三甲胺络合物 作用下, 以 四氢呋喃 为溶剂, 反应 0.17h, 生成 Methyl <2-(trimethylsilyl)ethyl 5-acetamido-4-O-benzoyl-3,5-dideoxy-9-O-(p-methoxybenzyl)-D-glycero-α-D-galacto-2-nonulopyranosid>onate
    参考文献:
    名称:
    Highly Stereoselective .alpha.-Sialylation. Synthesis of GM3-Saccharide and a Bis-Sialic Acid Unit
    摘要:
    The novel sialyl donor methyl [ethyl 5-acetamido-4,7,8,9-tetra-O-acetyl-2-thio-3-(phenylthic)-2,3,5- trideoxy-D-erythro -alpha-L-gluco-2-nonulopyranosid]onate (6) was synthesized in six steps from N-acetylneuraminic acid in an overall yield of 47%. Donor 6 was shown to be superior to conventional sialyl donors in that the sialylation yields were higher, even with sterically hindered and unreactive sialyl accepters, and the alpha/beta-selectivity was virtually complete.
    DOI:
    10.1021/jo00116a022
点击查看最新优质反应信息

文献信息

  • Synthesis of GD3-lactam: a potential ligand for the development of an anti-melanoma vaccine
    作者:Nafizal Hossain、Amparo Zapata、Mikael Wilstermann、Ulf J. Nilsson、Göran Magnusson
    DOI:10.1016/s0008-6215(02)00036-8
    日期:2002.4
    The novel sialyl donor methyl (ethyl 4,7,8,9-tetra-O-acetyl-5-N,N-diacetylamino-3,5-dideoxy-2-thio-3-thiophenyl-D-erthro-beta-L-gluco-non-2-ulopyranosid)onate was used for glycosylation of a lactosyl acceptor to give the GM3-trisaccharide derivative in 83% yield. Introduction of an azido group at C-9" of the GM3-trisaccharide derivative, transformation into a glycosyl acceptor, and sialylation with the above mentioned novel sialyl donor gave a GD3-trisaccharide in 50% yield. Reduction of the azido group gave the corresponding amine, which underwent spontaneous lactamization to the GD3-[1'''-9"]-lactam in an overall yield of 86%. Removal of protecting groups of over five steps, followed by per-O-acetylation gave an acetylated GD3-[1'''-9"]-lactam TMSEt glycoside in 27% overall yield. The acetylated GD3-[1'''-9"]-lactam TMSEt glycoside is suitable for glycosylation of linker-arms and the resulting linker-glycosides are planned to be coupled to carrier proteins. thus providing immunogens for trial vaccinations against malignant melanoma. (C) 2002 Elsevier Science Ltd. All rights reserved.
查看更多